This is BrainsWay’s global website. The global website is not intended for persons in the United States and includes information on clinical indications that were not cleared by the FDA, which are subject to further US regulatory review for safety and efficacy. BrainsWay is cleared by the FDA only for patients with MDD who failed to respond to one or more anti-depressants in the current episode, and for patients with OCD as an adjunct treatment.
With Achieve TMS opening up its 12th location in Andover, Massachusetts with an open house event, its another opportunity to bring BrainsWay’s Deep TMS technology to patients suffering from depression. With numerous locations, Achieve TMS East is one of the the largest providers of TMS in the country, and has chosen BrainsWay as its TMS technology, given its proven efficacy, safety, ease of use, and strong customer support. to BrainsWay.